TY - JOUR AU - Stuart, M. J. AU - Setty, B. N. PY - 2001 DA - 2001// TI - Hemostatic alterations in sickle cell disease: relationships to disease pathophysiology JO - Pediatr Pathol Mol Med VL - 20 UR - https://doi.org/10.1080/15513810109168816 DO - 10.1080/15513810109168816 ID - Stuart2001 ER - TY - JOUR AU - Ataga, K. I. AU - Orringer, E. P. PY - 2003 DA - 2003// TI - Hypercoagulability in sickle cell disease: a curious paradox JO - Am J Med VL - 115 UR - https://doi.org/10.1016/j.amjmed.2003.07.011 DO - 10.1016/j.amjmed.2003.07.011 ID - Ataga2003 ER - TY - JOUR AU - Tomer, A. PY - 2001 DA - 2001// TI - Thrombogenesis in sickle cell disease JO - J Lab Clin Med VL - 137 UR - https://doi.org/10.1067/mlc.2001.115450 DO - 10.1067/mlc.2001.115450 ID - Tomer2001 ER - TY - JOUR AU - Francis, R. B. PY - 1989 DA - 1989// TI - Elevated fibrin D-dimer fragment in sickle cell anemia: evidence for activation of coagulation during the steady state as well as in painful crisis JO - Haemostasis VL - 19 ID - Francis1989 ER - TY - JOUR AU - Westerman, M. P. PY - 1999 DA - 1999// TI - Antiphospholipid antibodies, proteins C and S, and coagulation changes in sickle cell disease JO - J Lab Clin Med VL - 134 UR - https://doi.org/10.1016/S0022-2143(99)90149-X DO - 10.1016/S0022-2143(99)90149-X ID - Westerman1999 ER - TY - JOUR AU - Wright, J. G. PY - 1997 DA - 1997// TI - Protein C and protein S in homozygous sickle cell disease: does hepatic dysfunction contribute to low levels? JO - Br J Haematol VL - 98 UR - https://doi.org/10.1046/j.1365-2141.1997.2663083.x DO - 10.1046/j.1365-2141.1997.2663083.x ID - Wright1997 ER - TY - JOUR AU - Zhou, L. AU - Schmaier, A. H. PY - 2005 DA - 2005// TI - Platelet aggregation testing in platelet-rich plasma: description of procedures with the aim to develop standards in the field JO - Am J Clin Pathol VL - 123 UR - https://doi.org/10.1309/Y9EC63RW3XG1V313 DO - 10.1309/Y9EC63RW3XG1V313 ID - Zhou2005 ER - TY - JOUR AU - Connor, W. E. PY - 1997 DA - 1997// TI - Abnormal phospholipid molecular species of erythrocytes in sickle cell anemia JO - J Lipid Res VL - 38 ID - Connor1997 ER - TY - JOUR AU - Ren, H. PY - 2005 DA - 2005// TI - Blood mononuclear cells and platelets have abnormal fatty acid composition in homozygous sickle cell disease JO - Ann Hematol VL - 84 UR - https://doi.org/10.1007/s00277-005-1023-7 DO - 10.1007/s00277-005-1023-7 ID - Ren2005 ER - TY - JOUR AU - Singer, P. AU - Wirth, M. PY - 2004 DA - 2004// TI - Can n-3 PUFA reduce cardiac arrhythmias? Results of a clinical trial JO - Prostaglandins Leukot Essent Fatty Acids VL - 71 UR - https://doi.org/10.1016/j.plefa.2004.03.003 DO - 10.1016/j.plefa.2004.03.003 ID - Singer2004 ER - TY - JOUR AU - Gao, L. G. PY - 2013 DA - 2013// TI - Influence of omega-3 polyunsaturated fatty acid-supplementation on platelet aggregation in humans: a meta-analysis of randomized controlled trials JO - Atherosclerosis VL - 226 UR - https://doi.org/10.1016/j.atherosclerosis.2012.10.056 DO - 10.1016/j.atherosclerosis.2012.10.056 ID - Gao2013 ER - TY - JOUR AU - Steinberg, M. H. PY - 2003 DA - 2003// TI - Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment JO - JAMA VL - 289 UR - https://doi.org/10.1001/jama.289.13.1645 DO - 10.1001/jama.289.13.1645 ID - Steinberg2003 ER - TY - JOUR AU - Colella, M. P. PY - 2012 DA - 2012// TI - Hydroxyurea is associated with reductions in hypercoagulability markers in sickle cell anemia JO - J Thromb Haemost VL - 10 UR - https://doi.org/10.1111/j.1538-7836.2012.04861.x DO - 10.1111/j.1538-7836.2012.04861.x ID - Colella2012 ER - TY - JOUR AU - McGann, P. T. AU - Ware, R. E. PY - 2011 DA - 2011// TI - Hydroxyurea for sickle cell anemia: what have we learned and what questions still remain? JO - Curr Opin Hematol VL - 18 UR - https://doi.org/10.1097/MOH.0b013e32834521dd DO - 10.1097/MOH.0b013e32834521dd ID - McGann2011 ER - TY - JOUR AU - Wang, W. C. PY - 2011 DA - 2011// TI - Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG) JO - Lancet VL - 377 UR - https://doi.org/10.1016/S0140-6736(11)60355-3 DO - 10.1016/S0140-6736(11)60355-3 ID - Wang2011 ER - TY - JOUR AU - Yan, J. H. PY - 2005 DA - 2005// TI - The influence of renal function on hydroxyurea pharmacokinetics in adults with sickle cell disease JO - J Clin Pharmacol VL - 45 UR - https://doi.org/10.1177/0091270004273526 DO - 10.1177/0091270004273526 ID - Yan2005 ER - TY - JOUR AU - Daak, A. A. PY - 2012 DA - 2012// TI - Effect of omega-3 (n-3) fatty acid supplementation in patients with sickle cell anemia: randomized, double-blind, placebo-controlled trial JO - Am J Clin Nutr VL - 97 UR - https://doi.org/10.3945/ajcn.112.036319 DO - 10.3945/ajcn.112.036319 ID - Daak2012 ER - TY - JOUR AU - Tomer, A. PY - 2001 DA - 2001// TI - Reduction of pain episodes and prothrombotic activity in sickle cell disease by dietary n-3 fatty acids JO - Thromb Haemost VL - 85 ID - Tomer2001 ER - TY - JOUR AU - Daak, A. A. PY - 2013 DA - 2013// TI - Docosahexaenoic and eicosapentaenoic acid supplementation does not exacerbate oxidative stress or intravascular haemolysis in homozygous sickle cell patients JO - Prostaglandins Leukot Essent Fatty Acids VL - 89 UR - https://doi.org/10.1016/j.plefa.2013.09.006 DO - 10.1016/j.plefa.2013.09.006 ID - Daak2013 ER - TY - JOUR AU - Daak, A. A. PY - 2015 DA - 2015// TI - Omega 3 (n-3) fatty acids down-regulate nuclear factor-kappa B (NF-kappaB) gene and blood cell adhesion molecule expression in patients with homozygous sickle cell disease JO - Blood Cells Mol Dis VL - 55 UR - https://doi.org/10.1016/j.bcmd.2015.03.014 DO - 10.1016/j.bcmd.2015.03.014 ID - Daak2015 ER - TY - JOUR AU - Okpala, I. PY - 2011 DA - 2011// TI - Pilot study of omega-3 fatty acid supplements in sickle cell disease JO - APMIS VL - 119 UR - https://doi.org/10.1111/j.1600-0463.2011.02751.x DO - 10.1111/j.1600-0463.2011.02751.x ID - Okpala2011 ER - TY - JOUR AU - Curtis, S. A. PY - 2015 DA - 2015// TI - Elevated steady state WBC and platelet counts are associated with frequent emergency room use in adults with sickle cell anemia JO - PLoS One VL - 10 UR - https://doi.org/10.1371/journal.pone.0133116 DO - 10.1371/journal.pone.0133116 ID - Curtis2015 ER - TY - JOUR AU - Ballas, S. K. PY - 1999 DA - 1999// TI - Erythropoietic activity in patients with sickle cell anaemia before and after treatment with hydroxyurea JO - Br J Haematol VL - 105 UR - https://doi.org/10.1111/j.1365-2141.1999.01339.x DO - 10.1111/j.1365-2141.1999.01339.x ID - Ballas1999 ER - TY - JOUR AU - Tripathi, A. AU - Jerrell, J. M. AU - Stallworth, J. R. PY - 2011 DA - 2011// TI - Clinical complications in severe pediatric sickle cell disease and the impact of hydroxyurea JO - Pediatr Blood Cancer VL - 56 UR - https://doi.org/10.1002/pbc.22822 DO - 10.1002/pbc.22822 ID - Tripathi2011 ER - TY - JOUR AU - Raffini, L. J. PY - 2006 DA - 2006// TI - Prolongation of the prothrombin time and activated partial thromboplastin time in children with sickle cell disease JO - Pediatr Blood Cancer VL - 47 UR - https://doi.org/10.1002/pbc.20579 DO - 10.1002/pbc.20579 ID - Raffini2006 ER - TY - JOUR AU - Chinawa, J. M. PY - 2013 DA - 2013// TI - Coagulation profile of children with sickle cell anemia in steady state and crisis attending the university of Nigeria teaching hospital, Ituku-Ozalla, Enugu JO - Niger J Clin Pract VL - 16 UR - https://doi.org/10.4103/1119-3077.110132 DO - 10.4103/1119-3077.110132 ID - Chinawa2013 ER - TY - JOUR AU - Bayazit, A. K. AU - Kilinc, Y. PY - 2001 DA - 2001// TI - Natural coagulation inhibitors (protein C, protein S, antithrombin) in patients with sickle cell anemia in a steady state JO - Pediatr Int VL - 43 UR - https://doi.org/10.1046/j.1442-200X.2001.01476.x DO - 10.1046/j.1442-200X.2001.01476.x ID - Bayazit2001 ER - TY - JOUR AU - De Franceschi, L. AU - Cappellini, M. D. AU - Olivieri, O. PY - 2011 DA - 2011// TI - Thrombosis and sickle cell disease JO - Semin Thromb Hemost VL - 37 UR - https://doi.org/10.1055/s-0031-1273087 DO - 10.1055/s-0031-1273087 ID - De Franceschi2011 ER - TY - JOUR AU - Heller, A. R. PY - 2002 DA - 2002// TI - Impact of n-3 fatty acid supplemented parenteral nutrition on haemostasis patterns after major abdominal surgery JO - Br J Nutr VL - 87 UR - https://doi.org/10.1079/BJN2001462 DO - 10.1079/BJN2001462 ID - Heller2002 ER - TY - JOUR AU - Vanschoonbeek, K. PY - 2004 DA - 2004// TI - Variable hypocoagulant effect of fish oil intake in humans: modulation of fibrinogen level and thrombin generation JO - Arterioscler Thromb Vasc Biol VL - 24 UR - https://doi.org/10.1161/01.ATV.0000137119.28893.0b DO - 10.1161/01.ATV.0000137119.28893.0b ID - Vanschoonbeek2004 ER - TY - JOUR AU - Nieuwenhuys, C. M. PY - 2001 DA - 2001// TI - Vitamin K-dependent and vitamin K-independent hypocoagulant effects of dietary fish oil in rats JO - Thromb Res VL - 104 UR - https://doi.org/10.1016/S0049-3848(01)00347-4 DO - 10.1016/S0049-3848(01)00347-4 ID - Nieuwenhuys2001 ER - TY - JOUR AU - Piccin, A. PY - 2015 DA - 2015// TI - Circulating microparticles, protein C, free protein S and endothelial vascular markers in children with sickle cell anaemia JO - J Extracell Vesicles VL - 4 UR - https://doi.org/10.3402/jev.v4.28414 DO - 10.3402/jev.v4.28414 ID - Piccin2015 ER - TY - JOUR AU - Hebbel, R. P. AU - Vercellotti, G. AU - Nath, K. A. PY - 2009 DA - 2009// TI - A systems biology consideration of the vasculopathy of sickle cell anemia: the need for multi-modality chemo-prophylaxsis JO - Cardiovasc Hematol Disord Drug Targets VL - 9 UR - https://doi.org/10.2174/1871529X10909040271 DO - 10.2174/1871529X10909040271 ID - Hebbel2009 ER - TY - JOUR AU - Marlar, R. A. AU - Kleiss, A. J. AU - Griffin, J. H. PY - 1982 DA - 1982// TI - Mechanism of action of human activated protein C, a thrombin-dependent anticoagulant enzyme JO - Blood VL - 59 ID - Marlar1982 ER - TY - JOUR AU - Koc, A. AU - Gumruk, F. AU - Gurgey, A. PY - 2003 DA - 2003// TI - The effect of hydroxyurea on the coagulation system in sickle cell anemia and beta-thalassemia intermedia patients: a preliminary study JO - Pediatr Hematol Oncol VL - 20 UR - https://doi.org/10.1080/08880010390220090 DO - 10.1080/08880010390220090 ID - Koc2003 ER - TY - JOUR AU - Ataga, K. I. PY - 2012 DA - 2012// TI - Association of coagulation activation with clinical complications in sickle cell disease JO - PLoS One VL - 7 UR - https://doi.org/10.1371/journal.pone.0029786 DO - 10.1371/journal.pone.0029786 ID - Ataga2012 ER - TY - JOUR AU - Shahar, E. PY - 1993 DA - 1993// TI - Associations of fish intake and dietary n-3 polyunsaturated fatty acids with a hypocoagulable profile. The atherosclerosis risk in communities (ARIC) study JO - Arterioscler Thromb VL - 13 UR - https://doi.org/10.1161/01.ATV.13.8.1205 DO - 10.1161/01.ATV.13.8.1205 ID - Shahar1993 ER - TY - JOUR AU - Nomura, S. AU - Kanazawa, S. AU - Fukuhara, S. PY - 2003 DA - 2003// TI - Effects of eicosapentaenoic acid on platelet activation markers and cell adhesion molecules in hyperlipidemic patients with type 2 diabetes mellitus JO - J Diabetes Complicat VL - 17 UR - https://doi.org/10.1016/S1056-8727(02)00172-1 DO - 10.1016/S1056-8727(02)00172-1 ID - Nomura2003 ER - TY - STD TI - Cottin SC, Sanders TA, Hall WL. The differential effects of EPA and DHA on cardiovascular risk factors. Proc Nutr Soc. 2011:1–17. ID - ref39 ER - TY - JOUR AU - Woodman, R. J. PY - 2003 DA - 2003// TI - Effects of purified eicosapentaenoic acid and docosahexaenoic acid on platelet, fibrinolytic and vascular function in hypertensive type 2 diabetic patients JO - Atherosclerosis VL - 166 UR - https://doi.org/10.1016/S0021-9150(02)00307-6 DO - 10.1016/S0021-9150(02)00307-6 ID - Woodman2003 ER - TY - JOUR AU - Adan, Y. PY - 1999 DA - 1999// TI - Effects of docosahexaenoic and eicosapentaenoic acid on lipid metabolism, eicosanoid production, platelet aggregation and atherosclerosis in hypercholesterolemic rats JO - Biosci Biotechnol Biochem VL - 63 UR - https://doi.org/10.1271/bbb.63.111 DO - 10.1271/bbb.63.111 ID - Adan1999 ER - TY - JOUR AU - Kollander, R. PY - 2010 DA - 2010// TI - Nuclear factor-kappa B (NFkappaB) component p50 in blood mononuclear cells regulates endothelial tissue factor expression in sickle transgenic mice: implications for the coagulopathy of sickle cell disease JO - Transl Res VL - 155 UR - https://doi.org/10.1016/j.trsl.2009.10.004 DO - 10.1016/j.trsl.2009.10.004 ID - Kollander2010 ER - TY - JOUR AU - Kalish, B. T. PY - 2015 DA - 2015// TI - Dietary omega-3 fatty acids protect against vasculopathy in a transgenic mouse model of sickle cell disease JO - Haematologica VL - 100 UR - https://doi.org/10.3324/haematol.2015.124586 DO - 10.3324/haematol.2015.124586 ID - Kalish2015 ER - TY - JOUR AU - Esmon, C. T. PY - 2005 DA - 2005// TI - The interactions between inflammation and coagulation JO - Br J Haematol VL - 131 UR - https://doi.org/10.1111/j.1365-2141.2005.05753.x DO - 10.1111/j.1365-2141.2005.05753.x ID - Esmon2005 ER -